RevivBio Inc.
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
RevivBio Inc. - overview
Established
2021
Location
Cambridge, MA, US
Primary Industry
Biotechnology
About
Based in Massachusetts, US, and founded in 2021, RevivBio operates as a biotechnology company that focuses on developing eco-friendly bio-inspired products for crop and animal health. In December 2023, RevivBio Inc. raised USD 2. 95 million in venture funding led by various investors.
The firm develops innovations that aim to protect plants and animals from resistant pests and pathogens. Additionally, the company is a developer of bone repair technology, providing a patented, synthetic, injectable, self-setting, and osteoconductive bone adhesive biomaterial. This biomaterial acts as a scaffold, facilitating bone growth, and is designed to be resorbed and replaced with new bone during the natural process of bone remodeling.
Primary Industry
Biotechnology
Sub Industries
Biotechnology
Website
www.revivbio.com/
Company Stage
Angel & Seed
Total Amount Raised
Subscriber access only
Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.